Complexa is dedicated to the discovery and development of proprietary intravenous and orally available small molecule drugs, modeled upon endogenously-occurring fatty acid signaling mediators, to treat diseases associated with kidney injury, inflammation and metabolic disorders.

Website: complexarx.com